comprehensive -WSS

comprehensive

author：fashion 2025-10-01 04:32:49 - browse：97

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft.

The first was her Polish-born maternal grandmother, who began showing symptoms when Schaeffer started college in 1981 and died seven years later. Then came her mother, a onetime Fulbright Scholar and high school language teacher who had been fluent in five languages but lost the ability to speak. She died in 2019. Last year, the disease killed Schaeffer’s mother’s sister, a former lab technician for Johnson & Johnson.

Schaeffer, a 59-year-old costume historian in North Berwick, Maine, has no symptoms of Alzheimer’s. But in 2021 her family history led her to apply to join a clinical trial testing a drug on people at risk for developing them. To participate, volunteers couldn’t have cognitive impairment. But they needed to test positive for a biomarker that put them at higher risk for mental decline ― deposits of a sticky toxic protein in the brain called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Hospital at home shows how to bring innovation to health care

hotspot

WSS

California store owner shot dead in dispute over displaying Pride flag: Police

FDA advisory panel to debate high blood pressure devices

PBMs are inflating the cost of generic drugs. They must be reined in

Trans patients at the end of life deserve respect and dignity

Former Pear Therapeutics executives start new VC firm

The surgeon had a dilemma only a Nazi medical text could resolve

focus

comprehensive

focus

Tori Bowie and the unacceptable rates of Black maternal death

Biotech venture capitalists face new demands from investors

As demand for Covid shots wanes, Moderna seeks its next success

How the first Native Hawaiian psychiatrist helped diversify medicine

Medicare details structure of new drug price negotiation program

Test for long Covid? Researchers find new clue in blood samples

23andMe had bad news about my health. I wish a person had delivered it

Kellogg’s is going to war over Mexico’s nutrition label rules

Alkermes shareholders re

As obesity drug market grows, telehealth companies court payers

hotspot

FDA clears AI tool for detecting skin cancer

Research misconduct: Proposed new rules face resistance

Elizabeth Holmes banned from government health programs

Biotech venture capitalists face new demands from investors

Humana cuts profit projections as Medicare Advantage costs soar

Francis Collins on trust in science and how Covid communications failed

hotspot

focus

hotspot

knowledge